Form 4: Hims & Hers CEO Dudum Reports Significant Trust Share Transfers

Hims & Hers Health, Inc. CEO Andrew Dudum reported several beneficial ownership changes involving transfers of Class A Common Stock between various family trusts and his direct holdings.

Summary

• Andrew Dudum, Chief Executive Officer, Director, and 10% Owner of Hims & Hers Health, Inc. (HIMS), reported changes in his beneficial ownership of Class A Common Stock.
• On November 28, 2025, 712,500 shares of Class A Common Stock were transferred from the Andrew Dudum 2015 Trust dated July 2, 2015, to Andrew Dudum's direct holdings.
• The Andrew Dudum 2015 Trust dated July 2, 2015, received an annuity payment-in-kind of 115,996 shares of Class A Common Stock from the AD 2022 GRAT 3 dated November 28, 2022.
• The AD 2022 GRAT 3 dated November 28, 2022, disposed of 1,078,549 shares of Class A Common Stock as a gift to the Dudum Legacy 2021 Trust.
• Following these transactions, Andrew Dudum's direct beneficial ownership stands at 805,023 shares of Class A Common Stock.
• Indirect beneficial ownership through various trusts includes 384,731 shares by the Andrew Dudum 2015 Trust, 1,080,972 shares by the Dudum Legacy 2021 Trust, and 0 shares by the AD 2022 GRAT 3, among other holdings.

Sentiment

Score: 6

Explanation: The transactions are primarily internal transfers and gifts for estate planning, which are neutral to slightly positive as they indicate a long-term holding strategy by the CEO and his family, rather than a sale for liquidity or a negative outlook.

Positives

• The transactions primarily involve internal reallocations and gifts among family trusts and the CEO's direct holdings, which are typically for estate planning purposes and do not indicate a negative outlook on the company.
• Andrew Dudum maintains substantial direct and indirect beneficial ownership in Hims & Hers Health, Inc., signaling continued long-term alignment with the company's performance and future.

Negatives

• No direct negatives related to company performance or insider sentiment are apparent from these trust-related transfers, as they are not open market sales for liquidity.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider ownership changes, primarily for estate planning purposes, and does not provide insights into broader industry trends or competitive landscape for Hims & Hers Health, Inc.

Related Party Transactions

• Andrew Dudum, CEO and Director, engaged in transfers of Class A Common Stock between his direct holdings and various family trusts (Andrew Dudum 2015 Trust, AD 2022 GRAT 3, Dudum Legacy 2021 Trust). These transactions, including a gift of 1,078,549 shares from one trust to another, are considered related party dealings as they involve entities beneficially owned or controlled by the reporting person.

Stakeholder Impact

• Shareholders: The transactions represent internal reallocations of shares by the CEO and his family, suggesting a continued long-term holding strategy rather than a change in investment sentiment that would directly impact other shareholders. No immediate impact on company operations or strategy is implied.

Key Dates

Recommendation

The Form 4 filing details internal transfers and gifts of shares by the CEO for estate planning purposes. These transactions do not reflect a change in the CEO's investment thesis or the company's operational performance. As such, they do not provide a basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate, pending further fundamental analysis of the company's financial health and strategic direction.

Keywords

Hims & Hers Health, HIMS, Andrew Dudum, SEC Form 4, Insider Transaction, Beneficial Ownership, Stock Transfer, Estate Planning, Trusts, Class A Common Stock